Anthony Petrone Stock Analyst Profile - Mizuho Research Coverage - Stocknear

Anthony Petrone

Stock Analyst at Mizuho

(4.39)
# 1622
Out of 5,506 analysts
198
Total ratings
Success rate
Average return

37 Stocks

Name Action PT Current % Upside Ratings Updated
GH Guardant Health
Maintains: Outperform
65 70
62.84 11.39% 3 Sep 25, 2025
ALC Alcon
Maintains: Outperform
120 110
77.39 42.14% 10 Aug 21, 2025
HAE Haemonetics
Maintains: Outperform
90 70
50.48 38.67% 12 Aug 8, 2025
LNTH Lantheus Holdings
Maintains: Outperform
120 70
53.83 30.04% 6 Aug 7, 2025
RMD ResMed
Maintains: Outperform
270 290
278.64 4.08% 13 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
130 135
130.94 3.1% 9 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
87 95
77.07 23.26% 9 Jul 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
140 135
134.58 0.31% 6 Jul 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
105 90
70.46 27.73% 11 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 18
27.14 -33.68% 8 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
98 100
97.7 2.35% 7 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 70
68.22 2.61% 9 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
58 70
41.43 68.96% 7 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
13 12
14.32 -16.2% 3 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
95 100
67.05 49.14% 2 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 175
87.39 100.25% 10 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
2
n/a n/a 1 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
20
14.71 35.96% 1 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
60
56.72 5.78% 1 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
54 58
65.17 -11% 2 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
70 60
53.37 12.42% 8 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
100 110
97.31 13.04% 8 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 14
14.66 -4.5% 6 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
110 105
76.56 37.15% 6 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
20 16
n/a n/a 3 Apr 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
250 250
76.64 226.2% 6 Mar 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
7.21 94.17% 4 Mar 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
350 390
452.35 -13.78% 6 Jan 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
63 67
87.85 -23.73% 2 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
75
n/a n/a 2 Jul 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
300
n/a n/a 1 Oct 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
200 175
100.78 73.65% 3 Nov 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
178
n/a n/a 5 Dec 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
30 25
11.94 109.38% 3 May 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25 15
n/a n/a 3 May 22, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
75
n/a n/a 1 Aug 9, 2017